🔓 Unlock the full profile of Suraj Madhavan (Innvocept Global Solutions), including verified contact details, financial insights, and professional associations.
See Suraj Madhavan Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sur*****@inn******.com
Mobile: 64509*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Suraj Madhavan co-founded Innvocept Global Solutions in September 2018, taking on the role of Chief Operating Officer, where efforts are focused on providing innovative solutions in the global healthcare landscape.
- Prior to Innvocept, Suraj served as Assistant General Manager in the Global Clinical Operations Department at Mylan from September 2016 to August 2018, contributing to the management of clinical trial operations across multiple regions.
- At PAREXEL, Suraj held two key positions: first as Clinical Operations Leader from July 2011 to October 2013, followed by Senior Clinical Operations Leader from November 2013 until September 2016, leading clinical teams in the execution of trials for new drug developments.
- Earlier experience includes the role of Associate Clinical Project Manager at Quintiles from April 2011 to March 2011, overseeing project management activities for clinical studies.
- Suraj also served as Associate Clinical Team Lead at Quintiles from April 2009 to March 2011, which involved coordinating team activities and progressing clinical trials effectively.
- Starting the career as Senior CRA at Quintiles from April 2008 to March 2009, responsibilities included monitoring clinical sites and ensuring compliance with regulatory standards.
- Experience also includes serving as Scientist II at Torrent Pharmaceuticals Ltd from July 2004 to December 2006, working on pharmaceutical product development and research initiatives.
- Suraj Madhavan has consistently demonstrated expertise in clinical operations and project management across several leading pharmaceutical companies, achieving significant milestones in clinical trial management and operations.